Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates.
about
Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX scoreDifferential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases.Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid.
P2860
Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preserving bone health in pati ...... : the role of bisphosphonates.
@en
Preserving bone health in pati ...... : the role of bisphosphonates.
@nl
type
label
Preserving bone health in pati ...... : the role of bisphosphonates.
@en
Preserving bone health in pati ...... : the role of bisphosphonates.
@nl
prefLabel
Preserving bone health in pati ...... : the role of bisphosphonates.
@en
Preserving bone health in pati ...... : the role of bisphosphonates.
@nl
P2093
P2860
P1433
P1476
Preserving bone health in pati ...... : the role of bisphosphonates.
@en
P2093
Kurt Miller
Per-Anders Abrahamsson
P2860
P304
P356
10.1111/J.1464-410X.2009.08952.X
P577
2009-12-01T00:00:00Z